119 related articles for article (PubMed ID: 31918642)
1. Expression of Hematopoietic Stem and Endothelial Cell Markers in Canine Hemangiosarcoma.
Kakiuchi-Kiyota S; Obert LA; Crowell DM; Xia S; Roy MD; Coskran TM; Kreeger JM; Crabbs TA; Cohen SM; Cattley RC; Cook JC
Toxicol Pathol; 2020 Apr; 48(3):481-493. PubMed ID: 31918642
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of human hemangiosarcomas and hemangiomas.
Liu L; Kakiuchi-Kiyota S; Arnold LL; Johansson SL; Wert D; Cohen SM
Hum Pathol; 2013 Oct; 44(10):2302-11. PubMed ID: 24054722
[TBL] [Abstract][Full Text] [Related]
3. Expression of platelet-derived growth factor and its receptors in spontaneous canine hemangiosarcoma and cutaneous hemangioma.
Asa SA; Murai A; Murakami M; Hoshino Y; Mori T; Maruo K; Khater A; El-Sawak A; el-Aziz EA; Yanai T; Sakai H
Histol Histopathol; 2012 May; 27(5):601-7. PubMed ID: 22419024
[TBL] [Abstract][Full Text] [Related]
4. Activation of matrix metalloproteinase (MMP)-2 by membrane type 1-MMP and abnormal immunolocalization of the basement membrane components laminin and type IV collagen in canine spontaneous hemangiosarcomas.
Murakami M; Sakai H; Kodama A; Yanai T; Mori T; Maruo K; Masegi T
Histol Histopathol; 2009 Apr; 24(4):437-46. PubMed ID: 19224446
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows novel parallels with human angiosarcoma.
Wong K; Ludwig L; Krijgsman O; Adams DJ; Wood GA; van der Weyden L
Dis Model Mech; 2021 Jul; 14(7):. PubMed ID: 34296746
[TBL] [Abstract][Full Text] [Related]
6. Identification of the two KIT isoforms and their expression status in canine hemangiosarcomas.
Chen YC; Liao JW; Hsu WL; Chang SC
BMC Vet Res; 2016 Jul; 12(1):142. PubMed ID: 27422008
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of expression profiles of hematopoietic stem cell, endothelial cell, and myeloid cell antigens in spontaneous and chemically induced hemangiosarcomas and hemangiomas in mice.
Kakiuchi-Kiyota S; Crabbs TA; Arnold LL; Pennington KL; Cook JC; Malarkey DE; Cohen SM
Toxicol Pathol; 2013 Jul; 41(5):709-21. PubMed ID: 23125116
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical Detection of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor in Canine Vascular Endothelial Tumours.
Anwar Sh; Yanai T; Sakai H
J Comp Pathol; 2015 Nov; 153(4):278-82. PubMed ID: 26286429
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophages in canine visceral hemangiosarcoma.
Kerboeuf M; Haugeberg DA; Olsen T; Sørling LK; Koppang EO; Moe L; Haaland AH
Vet Pathol; 2024 Jan; 61(1):32-45. PubMed ID: 37341055
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of procoagulant tissue factor expression in canine hemangiosarcoma cell lines.
Witter LE; Gruber EJ; Lean FZ; Stokol T
Am J Vet Res; 2017 Jan; 78(1):69-79. PubMed ID: 28029283
[TBL] [Abstract][Full Text] [Related]
11. Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization.
Gorden BH; Kim JH; Sarver AL; Frantz AM; Breen M; Lindblad-Toh K; O'Brien TD; Sharkey LC; Modiano JF; Dickerson EB
Am J Pathol; 2014 Apr; 184(4):985-995. PubMed ID: 24525151
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical demonstration of angiogenesis-associated homeobox proteins in canine vascular tumours.
Kodama A; Sakai H; Murakami M; Murai A; Mori T; Maruo K; Yanai T; Masegi T
J Comp Pathol; 2009; 141(2-3):199-203. PubMed ID: 19505696
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Peroxiredoxin 6 Protects Neoplastic Cells against Apoptosis in Canine Haemangiosarcoma.
Anwar Sh; Yanai T; Sakai H
J Comp Pathol; 2016 Jul; 155(1):29-39. PubMed ID: 27306414
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors.
Yonemaru K; Sakai H; Murakami M; Yanai T; Masegi T
Vet Pathol; 2006 Nov; 43(6):971-80. PubMed ID: 17099154
[TBL] [Abstract][Full Text] [Related]
15. Anticancer effects of resveratrol in canine hemangiosarcoma cell lines.
Carlson A; Alderete KS; Grant MKO; Seelig DM; Sharkey LC; Zordoky BNM
Vet Comp Oncol; 2018 Jun; 16(2):253-261. PubMed ID: 29235249
[TBL] [Abstract][Full Text] [Related]
16. Expression of the anti-apoptotic factors Bcl-2 and survivin in canine vascular tumours.
Murakami M; Sakai H; Kodama A; Mori T; Maruo K; Yanai T; Masegi T
J Comp Pathol; 2008 Jul; 139(1):1-7. PubMed ID: 18479697
[TBL] [Abstract][Full Text] [Related]
17. Claudin-5 protein is a new differential marker for histopathological differential diagnosis of canine hemangiosarcoma.
Jakab C; Halász J; Kiss A; Schaff Z; Rusvai M; Gálfi P; Abonyi TZ; Kulka J
Histol Histopathol; 2009 Jul; 24(7):801-13. PubMed ID: 19475526
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of p53 and pp53 Ser
García-Iglesias MJ; Cuevas-Higuera JL; Bastida-Sáenz A; de Garnica-García MG; Polledo L; Perero P; González-Fernández J; Fernández-Martínez B; Pérez-Martínez C
BMC Vet Res; 2020 Jul; 16(1):239. PubMed ID: 32660487
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma.
Adachi M; Hoshino Y; Izumi Y; Takagi S
J Vet Med Sci; 2016 May; 78(4):649-56. PubMed ID: 26685984
[TBL] [Abstract][Full Text] [Related]
20. The significance of p53 and retinoblastoma pathways in canine hemangiosarcoma.
Yonemaru K; Sakai H; Murakami M; Kodama A; Mori T; Yanai T; Maruo K; Masegi T
J Vet Med Sci; 2007 Mar; 69(3):271-8. PubMed ID: 17409643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
